UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 12, 2021
Accession Number:
Submission Type:
CIK: 0000868278
Company Name: ProPhase Labs, Inc.
File Number: 333-260848